NCK Pharma » Copanlisib

Bayer Advances Clinical Development Program for Investigational Cancer Drug Copanlisib

Posted on16 Apr 2015

TagsBayer, Bayer Advances Clinical Development Program for Investigational Cancer Drug Copanlisib, Copanlisib

Comments0

Bayer HealthCare today announced the expansion of its global clinical development program for the investigational oncology compound copanlisib (BAY 80-6946), which now...

Copanlisib

Bayer Advances Clinical Development Program for Investigational Cancer Drug Copanlisib

Our Popular Courses

Recent Articles

Course Category

Certification Courses

Corporate Training

Your form has been submitted

Server Side Error

Error